Back
NovaBay Pharmaceuticals Vs. DXP Enterprises Industry Stock Comparison
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
0.77
Seasonality Move:
-8.12%
Buy
65
DXPE
DXP Enterprises
Last Price:
61.63
Seasonality Move:
39.89%
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
- The current DXP Enterprises [DXPE] share price is $61.59. The Score for DXPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- DXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $61.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 62.96 | Buy |
| Chaikin Money Flow: | -5249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.73) | Buy |
| Bollinger Bands (100): | (0.3 - 1.8) | Sell |
DXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 171896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49 - 54.5) | Buy |
| Bollinger Bands (100): | (47.11 - 53.29) | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Buy |
| 20-day SMA: | 0.64 | Buy |
| 50-day SMA: | 0.6 | Buy |
| 200-day SMA: | 2.64 | Sell |
| 8-day EMA: | 0.71 | Buy |
| 20-day EMA: | 0.67 | Buy |
| 50-day EMA: | 0.75 | Buy |
| 200-day EMA: | 6.24 | Sell |
DXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.15 | Buy |
| 20-day SMA: | 51.64 | Buy |
| 50-day SMA: | 51.78 | Buy |
| 200-day SMA: | 47.83 | Buy |
| 8-day EMA: | 52.64 | Buy |
| 20-day EMA: | 51.7 | Buy |
| 50-day EMA: | 51.38 | Buy |
| 200-day EMA: | 47.37 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
DXP Enterprises Earnings Growth & DXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.30 per share.
NovaBay Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
DXP Enterprises Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||